Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2026-06-04 17:04:57 ET · period of report 2026-06-03 · accession 0002060594-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-04 17:04 | 2026-06-03 | RXRX | Bumpus Namandje | Dir | S - Sale | $3.54 | -4,386 | 43.2K | -9% | -$15.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-06-03 | S | D | 4,386 | $3.54 | 43,171 | D | — | — | (F1) This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. |